Skip to main content

Table 4 Concordance of Cav-1 and pERK expression in matched primary and secondary metastatic tumours

From: Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease

Primary

Metastatic

Concordance

Biomarker

Cav (-)

Cav (+)

pERK (-)

pERK (+)

Concordant / Total

Kappa

P

Cav (-)

3

0

 

14/16

0.67

P = 0.004

Cav (+)

2

11

pERK (-)

 

1

0

15/16

0.64

P = 0.006

pERK (+)

1

14

 

Cav(-) pERK(-)

Cav(+) pERK(-)

Cav(-) pERK(+)

Cav(+) pERK(+)

   

Cav(-)/pERK(-)

0

0

0

0

14/16

0.74

P < 0.001

Cav(+)/pERK(-)

0

1

0

0

Cav(-)/pERK(+)

0

0

3

0

Cav(+)/pERK(+)

1

0

1

10